Antibody Response to Severe Acute Respiratory Syndrome‐Coronavirus‐2 Messenger RNA Vaccines in Liver Transplant Recipients

Alexandra T. Strauss, Andrew M. Hallett, Brian J. Boyarsky, Michael T. Ou, William A. Werbel, Robin K. Avery, Aaron A. R. Tobian, Allan B. Massie, James P. A. Hamilton, Jacqueline M. Garonzik‐Wang, Dorry L. Segev – 17 August 2021

Novel Composite Endpoint for Assessing Outcomes in Liver Transplantation: Arterial and Biliary Complication–Free Survival

Eric Savier, Yann De Rycke, Chetana Lim, Claire Goumard, Geraldine Rousseau, Fabiano Perdigao, Pierre Rufat, Chady Salloum, Laura Llado, Emilio Ramos, Josefina Lopez‐Dominguez, Alba Cachero, Joan Fabregat, Daniel Azoulay, Olivier Scatton – 16 August 2021 – Transplant and patient survival are the validated endpoints to assess the success of liver transplantation (LT). This study evaluates arterial and biliary complication–free survival (ABCFS) as a new metric.

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC

Alberto Zanetto, Elena Campello, Cristiana Bulato, Sabrina Gavasso, Graziella Saggiorato, Sarah Shalaby, Luca Spiezia, Umberto Cillo, Fabio Farinati, Francesco Paolo Russo, Patrizia Burra, Marco Senzolo, Paolo Simioni – 15 August 2021 – In patients with cirrhosis, particularly those with hepatocellular carcinoma (HCC), hypercoagulability may be associated with purported increased risks of portal vein thrombosis and cirrhosis progression.

Hepatitis E virus infection activates NOD‐like receptor family pyrin domain‐containing 3 inflammasome antagonizing interferon response but therapeutically targetable

Yang Li, Peifa Yu, Amy L. Kessler, Jingyi Shu, Xiaoyan Liu, Zhaochao Liang, Jiaye Liu, Yunlong Li, Pengfei Li, Ling Wang, Yining Wang, Zhongren Ma, Aixia Liu, Ling Wang, Marco J. Bruno, Robert A. Man, Maikel P. Peppelenbosch, Sonja I. Buschow, Lin Wang, Yijin Wang, Qiuwei Pan – 14 August 2021

Subscribe to